Orthofix Medical Inc, formerly Orthofix International NV is a medical device company that provides reconstructive and regenerative orthopedic and spine solutions to physicians. The firm operates in four segments: BioStim, Biologics, Extremity Fixation, and Spine Fixation. The BioStim business generates the largest proportion of revenue and sells devices that enhance bone fusion. The Biologics business markets a portfolio of regenerative products and tissue forms used by physicians to treat spinal and orthopedic conditions. The Extremity Fixation unit sells products used for fracture repair and bone reconstruction procedures. The Spine Fixation unit sells implant products used in spine surgery. Orthofix generates the vast majority of its revenue in the United States.
| Website: | www.orthofix.com |
| Email: | markquick@orthofix.com |
| Main Phone: | +1 800 527-0404 |
| Address: | 3451 Plano Parkway |
| State: | TX |
| City / Town: | Lewisville |
| Country: | USA |
| Postal Code: | 75056 |
| Exchange: | NGS |
| CEO: | Bradley R. Mason |
| Employees: | 858 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
| Last Price 54.90 | Change $ -1.21 | Change % -2.16 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open 55.82 | High 56.19 | Low 54.69 | Prev Close 56.11 |
| Last Trade | Volume 61,139 | 52 Wk Hi 63.57 | 52 Wk Low 50.41 |
| Market Cap 1 bi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 18,920,827.00 | EPS (TTM) 0.34 | PE Ratio 161.50 | Exchange NGS |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 9 | 37 |
| Number of Buys | 9 | 26 |
| Number of Sells | 0 | 11 |
| Net Activity | 48070 | 67650 |
| Last 10 Buys | Shares |
|---|---|
| Ronald A. Matricaria | 1,000 |
| Ronald A. Matricaria | 1,000 |
| Ronald A. Matricaria | 1,000 |
| Ronald A. Matricaria | 1,000 |
| Ronald A. Matricaria | 1,000 |
| Ronald A. Matricaria | 1,000 |
| Ronald A. Matricaria | 1,000 |
| James Hinrichs | 1,000 |
| Mark A. Heggestad | 1,000 |
| Emily Buxton | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Brad Niemann | 1,000 |
| Bradley R. Mason | 1,000 |
| Luke T. Faulstick | 1,000 |
| Doug Rice | 1,000 |
| Brad Niemann | 1,000 |
| Bradley R. Mason | 1,000 |
| Raymond Fujikawa | 1,000 |
| Bradley R. Mason | 1,000 |
| Bradley R. Mason | 1,000 |
| Michael M. Finegan | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 72 | 72 | 72 | 72 |
| Low Target Price Estimate | 52 | 52 | 52 | 52 |
| Mean Target Price Estimate | 63.6 | 64 | 64 | 63.6 |
| Standard Deviation | 7.54 | 8.64 | 8.64 | 7.54 |
| Date of Most Recent Estimate | 06/01/18 | 05/24/18 | 05/02/18 | 06/01/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-15 |
| SD | Specialized Disclosure Report | 6 | 2018-05-30 |
| 424B3 | Prospectus filed under Rule 424(b)(3) | 184 | 2018-05-30 |
| EFFECT | Notice from the SEC of registration effectiveness | 1 | 2018-05-29 |
| S-4/A | Pre-effective amendment to an S-4 filing | 195 | 2018-05-24 |
| 8-K/A | Amendment to a previously filed 8-K | 43 | 2018-05-15 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-07 |
| S-8 | Securities offered to employees under employee benefit plans | 47 | 2018-04-30 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 165 | 2018-04-30 |
| 8-K | Report of unscheduled material events or corporate changes. | 13 | 2018-04-30 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 6 | 5 | 5 | 5 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1 | 1 | 1 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
